Physician profile
Christopher Panetta
NPI 1538311220
$8,582.92
in general payments reported to CMS, 2019-2025
7 companies · $450 in 2025
The $450 reported for 2025 was more than what 78% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $533 · 2022: $46.18 · 2023: $1,079 · 2024: $6,475 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,965 · Food and Beverage: $1,071 · Travel and Lodging: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,965.00 |
| Food and Beverage | $1,071.31 |
| Travel and Lodging | $967.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maquet Cardiovascular L.L.C. | $7,165.27 | 2023-2024 | Rotaflow, Vasoview Hemopro 2 |
| Getinge USA Sales, LLC | $541.75 | 2021-2024 | Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $337.98 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $332.25 | 2025 | |
| Silk Road Medical, INC. | $124.57 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lemaitre Vascular, INC. | $57.11 | 2024-2025 | Tyke, Patch, Pledget and Intracardiac, Pruitt Irrigation Occlusion Catheter, Restoreflow |
| Abbott Laboratories | $23.99 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Panetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.